SCHEDULE: Millennium Management Discloses BellRing Brands Stake

Millennium Management LLC, Millennium Group Management LLC, and Israel A. Englander have jointly filed a Schedule 13G, reporting beneficial ownership of 3.6% of BellRing Brands, Inc. common stock as of June 23, 2026.

Summary

• Millennium Management LLC, Millennium Group Management LLC, and Israel A. Englander have filed a joint Schedule 13G statement regarding their beneficial ownership of BellRing Brands, Inc. common stock.
• As of June 23, 2026, the reporting persons collectively beneficially owned 4,136,176 shares of BellRing Brands, Inc. common stock.
• This ownership stake represents 3.6% of the class of securities.
• The filing indicates that the reporting persons ceased to be beneficial owners of more than 5% of the outstanding common stock by the date of this filing, implying a reduction in their stake after initially crossing the 5% threshold on June 23, 2026.
• The securities are held by entities subject to the voting control and investment discretion of Millennium Management LLC and/or other investment managers controlled by Millennium Group Management LLC and Mr. Englander.
• A joint filing agreement confirms the coordinated filing among the parties.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing. It's a standard disclosure of beneficial ownership and does not contain operational or financial performance data, nor does it indicate any strategic intent beyond passive investment.

Positives

• The filing provides transparency regarding significant institutional ownership in BellRing Brands, Inc.
• The reporting persons have a substantial beneficial ownership of 4,136,176 shares, representing 3.6% of the class.

Negatives

• The filing notes that the reporting persons ceased to be beneficial owners of more than 5% of the outstanding common stock by the date of this filing, suggesting a potential reduction in their holdings or a shift in reporting thresholds.
• The complex ownership structure involving multiple entities and investment managers may obscure direct control and decision-making.

Risks

• Potential for future changes in beneficial ownership, as indicated by the statement that the reporting persons ceased to be beneficial owners of more than 5% by the filing date.
• The reliance on investment managers controlled by Millennium Group Management LLC and Mr. Englander introduces a layer of indirect control, which could lead to strategic shifts not directly attributable to the named entities.

Future Outlook

The filing does not contain forward-looking statements or guidance. It primarily reports on past ownership status and confirms a joint filing agreement.

Management Comments

• The filing includes a certification by the reporting persons stating that the securities were not acquired or held for the purpose of or with the effect of changing or influencing the control of the issuer.

Industry Context

StockSavvy.ai notes that Schedule 13G filings are common for institutional investors and hedge funds like Millennium Management when their beneficial ownership of a public company's stock crosses a certain threshold (typically 5%). This filing indicates a significant, albeit passive, investment in BellRing Brands, Inc. within the consumer staples sector.

Stakeholder Impact

• Shareholders: Increased transparency regarding institutional ownership, which can influence market perception and trading activity.
• BellRing Brands, Inc.: The filing confirms a significant institutional investor's interest, which could be viewed positively by the market.

Next Steps

• Continued monitoring of BellRing Brands, Inc. by Millennium Management LLC, Millennium Group Management LLC, and Israel A. Englander, with potential adjustments to their beneficial ownership.
• Potential for future filings if ownership levels change significantly.

Key Dates

Keywords

BellRing Brands, Schedule 13G, Millennium Management, Millennium Group Management, Israel A. Englander, Beneficial Ownership, Common Stock, SEC Filing, Investment Management